icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
3 Mar, 2021 09:05

South Korea launches investigation into deaths of 2 people days after receiving AstraZeneca Covid-19 vaccine

South Korea launches investigation into deaths of 2 people days after receiving AstraZeneca Covid-19 vaccine

South Korea’s Disease Control and Prevention Agency has launched an investigation into the cause of the deaths of two people days after receiving the Oxford/AstraZeneca Covid-19 vaccine.

The two individuals, who weren’t related and had pre-existing conditions, passed away on Tuesday and Wednesday after falling ill shortly following receiving their vaccination.

A 63-year-old nursing home resident, who was previously diagnosed with cerebrovascular disease, developed fatal blood poisoning and pneumonia after experiencing a severe fever.

The other victim was an individual who was in their 50s and had a history of cardiac disorder and diabetes. They suffered several heart attacks a day after taking the vaccine.

The Korea Disease Control and Prevention Agency only confirmed that it was investigating what caused the deaths. However, they did not confirm the victims or provide any further information about their investigation.

Also on rt.com ‘Third wave is not over’: South Korean PM warns against easing anti-coronavirus restrictions as infection numbers grow

AstraZeneca declined to comment, with a company spokesperson in Seoul saying they had no statement to make at this time.

South Korea has previously advised that individuals 65 and over should not receive the vaccine, as they believe there is not enough data to prove it is safe and effective for that age group.

However, no concerns have been raised by health officials in the country for individuals with pre-existing conditions.

The South Korean Ministry of Food and Drug Safety approved the use of the Oxford/AstraZeneca vaccine for use on February 10, with inoculations starting on February 26. As of Tuesday evening, 85,904 people had received at least one dose of the AstraZeneca vaccine in South Korea.

Think your friends would be interested? Share this story!